L1210 cell variants selected in the presence of the lipophilic dihydrofolate reductase inhibitor, metoprine, expressed increased levels of one-carbon, reduced folate transport inward (Sirotnak, F. M., Moccio, D. M., and Yang, C.-H.(1984) J. Biol. Chem. 259, 13139-13144). Growth of one of these variants (L1210/R69), with metoprine in the presence of decreasing concentrations of l,L5-CHO-folateH (natural diastereoisomer of 5-formyltetrahydrofolate), resulted in the selection of other variants (L1210/R82, R83, and R84) with further reduction in one-carbon, reduced folate transport and in two cases (L1210/R83 and R84) with 3-8-fold increased folylpolyglutamate synthetase (FPGS) activity and folate compound polyglutamate formation in situ. Metoprine resistance was further increased, and the requirement for exogenous folate during growth was decreased as well in these variants. The increase in FPGS activity observed in L1210/R83 and R84 was characterized by 3- and 8-fold increases in value for V with no change in K and the same increase in a 60-61-kDa protein as shown by immunoblotting. Northern blotting revealed the same increases in these two variants in the level of a 2.3-kilobase FPGS mRNA when compared with control, while Southern blotting of genomic DNA did not reveal any increase in FPGS gene-copy number or restriction polymorphisms. Also, no difference in stability of FPGS mRNA was found between parental and variant cells. In contrast, nuclear run-on assays revealed differences among these cell types in the rate of FPGS mRNA transcription that correlated with increased FPGS activity, protein, and mRNA level in the variants. Similar studies with a transport-defective, methotrexate-resistant L1210 cell variant (L1210/R25) documented a 2-3-fold decrease in FPGS activity, protein, and mRNA levels that was accounted for by a decrease in FPGS mRNA transcription. These results provide the first examples of constituitively altered transcriptional regulation of FPGS activity associated with acquired resistance to antifolates.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				F. M. Sirotnak RESPONSE: Re: Folylpolyglutamyl Synthetase Gene Transfer and Glioma Antifolate Sensitivity in Culture and In Vivo J Natl Cancer Inst, December 1, 1999; 91(23): 2049 - 2050. [Full Text] [PDF]

				M. Aghi, C. M. Kramm, and X. O. Breakefield Folylpolyglutamyl Synthetase Gene Transfer and Glioma Antifolate Sensitivity in Culture and In Vivo J Natl Cancer Inst, July 21, 1999; 91(14): 1233 - 1241. [Abstract] [Full Text] [PDF]

				S. J. Freemantle and R. G. Moran Transcription of the Human Folylpoly-gamma -glutamate Synthetase Gene J. Biol. Chem., October 3, 1997; 272(40): 25373 - 25379. [Abstract] [Full Text] [PDF]

				M. C. Waltham, W.-W. Li, H. Gritsman, W. P. Tong, and J. R. Bertino gamma -Glutamyl Hydrolase from Human Sarcoma HT-1080 Cells: Characterization and Inhibition by Glutamine Antagonists Mol. Pharmacol., May 1, 1997; 51(5): 825 - 832. [Abstract] [Full Text]

				K. Roy, M. G. Egan, S. Sirlin, and F. M. Sirotnak Posttranscriptionally Mediated Decreases in Folylpolyglutamate Synthetase Gene Expression in Some Folate Analogue-resistant Variants of the L1210 Cell. EVIDENCE FOR AN ALTERED COGNATE mRNA IN THE VARIANTS AFFECTING THE RATE OF DE NOVO SYNTHESIS OF THE ENZYME J. Biol. Chem., March 14, 1997; 272(11): 6903 - 6908. [Abstract] [Full Text] [PDF]

				K. Roy, K. Mitsugi, and F. M. Sirotnak Additional Organizational Features of the Murine Folylpolyglutamate Synthetase Gene. TWO REMOTELY SITUATED EXONS ENCODING AN ALTERNATE 5prime END AND PROXIMAL OPEN READING FRAME UNDER THE CONTROL OF A SECOND PROMOTER J. Biol. Chem., February 28, 1997; 272(9): 5587 - 5593. [Abstract] [Full Text] [PDF]

				K. Roy, K. Mitsugi, and F. M. Sirotnak Organization and Alternate Splicing of the Murine Folylpolyglutamate Synthetase Gene. DIFFERENT SPLICE VARIANTS IN L1210 CELLS ENCODE MITOCHONDRIAL OR CYTOSOLIC FORMS OF THE ENZYME J. Biol. Chem., September 27, 1996; 271(39): 23820 - 23827. [Abstract] [Full Text] [PDF]